NASDAQ:LMAT - LeMaitre Vascular Stock Price, Forecast & News

LeMaitre Vascular trades on the NASDAQ under the ticker symbol "LMAT."

LeMaitre Vascular declared a quarterly dividend on Monday, October 21st. Shareholders of record on Wednesday, November 20th will be given a dividend of $0.085 per share on Thursday, December 5th. This represents a $0.34 annualized dividend and a yield of 0.93%. The ex-dividend date is Tuesday, November 19th. View LeMaitre Vascular's Dividend History.

LeMaitre Vascular Inc (NASDAQ:LMAT) released its quarterly earnings results on Wednesday, October, 23rd. The medical instruments supplier reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.21 by $0.04. The medical instruments supplier earned $29.10 million during the quarter, compared to analyst estimates of $28.15 million. LeMaitre Vascular had a net margin of 16.76% and a return on equity of 13.38%. The business's quarterly revenue was up 20.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.21 earnings per share. View LeMaitre Vascular's Earnings History.

LeMaitre Vascular is scheduled to release their next quarterly earnings announcement on Tuesday, February 18th 2020. View Earnings Estimates for LeMaitre Vascular.

4 Wall Street analysts have issued 12 month price targets for LeMaitre Vascular's shares. Their forecasts range from $37.00 to $40.00. On average, they anticipate LeMaitre Vascular's stock price to reach $39.00 in the next twelve months. This suggests a possible upside of 7.1% from the stock's current price. View Analyst Price Targets for LeMaitre Vascular.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LeMaitre Vascular in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for LeMaitre Vascular.

Media stories about LMAT stock have trended somewhat negative this week, according to InfoTrie. The research firm identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. LeMaitre Vascular earned a daily sentiment score of -1.0 on InfoTrie's scale. They also gave news coverage about the medical instruments supplier a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the near term. View News Stories for LeMaitre Vascular.

Some companies that are related to LeMaitre Vascular include Cantel Medical (CMD), Irhythm Technologies (IRTC), Glaukos (GKOS), Merit Medical Systems (MMSI), Inspire Medical Systems (INSP), Cardiovascular Systems (CSII), AtriCure (ATRC), Atrion (ATRI), Silk Road Medical (SILK), Shockwave Medical (SWAV), Cryolife (CRY), Tactile Systems Technology (TCMD), Luminex (LMNX), Axonics Modulation Technologies (AXNX) and Orthofix Medical (OFIX).

Based on aggregate information from My MarketBeat watchlists, some companies that other LeMaitre Vascular investors own include Canopy Growth (CGC), AbbVie (ABBV), Sociedad Quimica y Minera de Chile (SQM), Gilead Sciences (GILD), NVIDIA (NVDA), Aurora Cannabis (ACB), Aurora Cannabis (ACBFF), Adobe (ADBE), Boeing (BA) and Teva Pharmaceutical Industries (TEVA).

LeMaitre Vascular's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Conestoga Capital Advisors LLC (8.58%), Summit Creek Advisors LLC (1.61%), Wedge Capital Management L L P NC (0.35%), Campbell & CO Investment Adviser LLC (0.03%), Louisiana State Employees Retirement System (0.03%) and Nisa Investment Advisors LLC (0.02%). Company insiders that own LeMaitre Vascular stock include David B Roberts, George W Lemaitre, Joseph P Pellegrino Jr, Lawrence J Jasinski, Michael H Thomas and Trent G Kamke. View Institutional Ownership Trends for LeMaitre Vascular.

LMAT stock was sold by a variety of institutional investors in the last quarter, including Conestoga Capital Advisors LLC and Louisiana State Employees Retirement System. Company insiders that have sold LeMaitre Vascular company stock in the last year include David B Roberts, George W Lemaitre, Joseph P Pellegrino Jr, Lawrence J Jasinski, Michael H Thomas and Trent G Kamke. View Insider Buying and Selling for LeMaitre Vascular.

LMAT stock was purchased by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC, Summit Creek Advisors LLC, Campbell & CO Investment Adviser LLC and Nisa Investment Advisors LLC. View Insider Buying and Selling for LeMaitre Vascular.

Shares of LMAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of LMAT stock can currently be purchased for approximately $36.40.

LeMaitre Vascular has a market capitalization of $727.64 million and generates $105.57 million in revenue each year. The medical instruments supplier earns $22.94 million in net income (profit) each year or $0.84 on an earnings per share basis. View Additional Information About LeMaitre Vascular.

The official website for LeMaitre Vascular is http://www.lemaitre.com/.

LeMaitre Vascular's mailing address is 63 SECOND AVENUE, BURLINGTON MA, 01803. The medical instruments supplier can be reached via phone at 781-221-2266.